Periodontal Disease and Breast Cancer Risk: Results from the Nurses' Health Study.


Journal

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
ISSN: 1538-7755
Titre abrégé: Cancer Epidemiol Biomarkers Prev
Pays: United States
ID NLM: 9200608

Informations de publication

Date de publication:
09 2021
Historique:
received: 23 02 2021
revised: 13 05 2021
accepted: 15 06 2021
pubmed: 1 7 2021
medline: 9 3 2022
entrez: 30 6 2021
Statut: ppublish

Résumé

While periodontal disease has been linked to increased cancer risk, studies regarding an association with breast cancer are limited. We examined the relationship between self-reported diagnosis of periodontal bone loss and incidence of breast cancer in a large, prospective cohort study, the Nurses' Health Study (1998-2014). We calculated HRs using Cox proportional hazards modeling, adjusting for risk factors common to both periodontal disease and breast cancer. During 1,023,647 person-years of follow-up, 5,110 of breast cancer cases were reported. We observed no association between periodontal disease and overall breast cancer risk (HR, 1.02; 95% confidence interval: 0.94-1.10); the association was not modified by smoking status, or other breast cancer risk factors or by breast tumor subtypes. We did not observe any association between periodontal disease and breast cancer risk. Given inconsistent findings in the literature, further research with standardized clinical measures of periodontitis is warranted.

Sections du résumé

BACKGROUND
While periodontal disease has been linked to increased cancer risk, studies regarding an association with breast cancer are limited.
METHODS
We examined the relationship between self-reported diagnosis of periodontal bone loss and incidence of breast cancer in a large, prospective cohort study, the Nurses' Health Study (1998-2014). We calculated HRs using Cox proportional hazards modeling, adjusting for risk factors common to both periodontal disease and breast cancer.
RESULTS
During 1,023,647 person-years of follow-up, 5,110 of breast cancer cases were reported. We observed no association between periodontal disease and overall breast cancer risk (HR, 1.02; 95% confidence interval: 0.94-1.10); the association was not modified by smoking status, or other breast cancer risk factors or by breast tumor subtypes.
CONCLUSIONS
We did not observe any association between periodontal disease and breast cancer risk.
IMPACT
Given inconsistent findings in the literature, further research with standardized clinical measures of periodontitis is warranted.

Identifiants

pubmed: 34187855
pii: 1055-9965.EPI-21-0257
doi: 10.1158/1055-9965.EPI-21-0257
pmc: PMC8419105
mid: NIHMS1722157
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1757-1760

Subventions

Organisme : NCI NIH HHS
ID : P01 CA087969
Pays : United States
Organisme : NCI NIH HHS
ID : R25 CA113951
Pays : United States
Organisme : NCI NIH HHS
ID : T32 CA113951
Pays : United States
Organisme : NCI NIH HHS
ID : UM1 CA186107
Pays : United States

Informations de copyright

©2021 American Association for Cancer Research.

Références

Periodontol 2000. 2020 Jun;83(1):213-233
pubmed: 32385885
J Public Health Dent. 2002 Spring;62(2):115-21
pubmed: 11989206
Nat Rev Cancer. 2005 May;5(5):388-96
pubmed: 15864280
Front Oncol. 2018 Dec 12;8:601
pubmed: 30619743
Periodontol 2000. 2020 Jun;83(1):7-13
pubmed: 32385880
Cancer Prev Res (Phila). 2020 Dec;13(12):1007-1016
pubmed: 32727823

Auteurs

Zeinab Farhat (Z)

Department of Epidemiology and Environmental Health, School of Public Health and Health Professions, University at Buffalo, State University of New York, Buffalo, New York. zfarhat@buffalo.edu.

Claire Cadeau (C)

Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.

A Heather Eliassen (AH)

Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.

Jo L Freudenheim (JL)

Department of Epidemiology and Environmental Health, School of Public Health and Health Professions, University at Buffalo, State University of New York, Buffalo, New York.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH